Synthetic cannabis reduces agitation in Alzheimer’s patients - Stock Watch Index

Synthetic cannabis reduces agitation in Alzheimer’s patients

October 4, 2024

An FDA-approved synthetic version of THC (the main ingredient in cannabis) reduces agitation in patients with Alzheimer’s disease.

Search

RECENT PRESS RELEASES

The 15 best Prime Day tech deals to shop early, including $50 off AirPods

SWI Editorial Staff2024-10-04T13:56:25-07:00October 4, 2024|

A National Movement to Organize Amazon Takes Off

SWI Editorial Staff2024-10-04T13:56:18-07:00October 4, 2024|

Amazon Prime Day: Best 125+ deals live ahead of October’s Big Deal Days sale

SWI Editorial Staff2024-10-04T13:56:16-07:00October 4, 2024|

5 Amazon deals we predict will sell out for Prime Big Deal Days 2024

SWI Editorial Staff2024-10-04T13:56:15-07:00October 4, 2024|

Bitcoin ‘Uptober’ Might Finally Be Getting Started—Here’s Why

SWI Editorial Staff2024-10-04T13:54:49-07:00October 4, 2024|

HBO Is Joining Search for Bitcoin’s Satoshi. Past Attempts Haven’t Turned Out Great.

SWI Editorial Staff2024-10-04T13:54:48-07:00October 4, 2024|

Related Post